Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations
- Alan L. Ho
- , Irene Brana
- , Robert Haddad
- , Jessica Bauman
- , Keith Bible
- , Sjoukje Oosting
- , Deborah J. Wong
- , Myung Ju Ahn
- , Valentina Boni
- , Caroline Even
- , Jerome Fayette
- , Maria José Flor
- , Kevin Harrington
- , Sung Bae Kim
- , Lisa Licitra
- , Ioanna Nixon
- , Nabil F. Saba
- , Stephan Hackenberg
- , Pol Specenier
- , Francis Worden
- Memorial Sloan-Kettering Cancer Center
- Cornell University
- Vall d'Hebron Institute of Oncology
- Dana-Farber Cancer Institute
- Mayo Clinic
- University of Groningen
- University of California at Los Angeles
- Sungkyunkwan University
- START Madrid-CIOCC
- Université Paris-Sud
- Centre Léon Bérard
- Hospital Universitario Virgen del Rocio
- Royal Marsden Hospital
- University of Ulsan
- University of Milan
- Beatson Oncology Centre
- Emory University
- University of Würzburg
- University of Antwerp
- University of Michigan, Ann Arbor
- Kura Oncology Inc
Research output: Contribution to journal › Article › peer-review
182
Scopus
citations